Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Specific Diagnostics
Specific Diagnostics

Specific Diagnostics

Series B

Global pioneer in rapid antibiotic susceptibility solutions, Specific Diagnostics.

HQ
Mountain View, CA, US
Founded
2011
Overview
Compare
Fundraising
Employees

Specific Diagnostics is a global pioneer in rapid antibiotic susceptibility solutions. The company focuses on developing innovative diagnostic tools to quickly determine the most effective antibiotics for treating infections, addressing the urgent need for faster and more accurate medical responses. Their market focus includes healthcare providers and laboratories worldwide.

Specific Diagnostics has made significant strides in the medical diagnostics field, contributing to improved patient outcomes and combating antibiotic resistance. Their cutting-edge technology has garnered attention and support from leading healthcare institutions and investors, solidifying their impact and reputation in the industry.

Specific Diagnostics - Similar Companies

IES Diagnostics logo

IES Diagnostics

Instadiagnostics logo

Instadiagnostics

BioAmp diagnostics logo

BioAmp diagnostics

bioampdx.com

Nowdiagnostics logo

Nowdiagnostics

nowdx.com

DxTerity Diagnostics logo

DxTerity Diagnostics

dxterity.com

Gaskiya Diagnostics logo

Gaskiya Diagnostics

Selux Diagnostics logo

Selux Diagnostics

seluxdx.com

First Light Diagnostics logo

First Light Diagnostics

firstlightbio.com

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Rapid Diagnostek logo

Rapid Diagnostek

Bold Diagnostics logo

Bold Diagnostics

Critical Diagnostics logo

Critical Diagnostics

Plasmonic Diagnostics logo

Plasmonic Diagnostics

Sword Diagnostics logo

Sword Diagnostics

Babson Diagnostics logo

Babson Diagnostics

babsondx.com

Specific Diagnostics - Quick Facts

Who are Specific Diagnostics' competitors?

Companies similar to Specific Diagnostics include IES Diagnostics, Instadiagnostics, BioAmp diagnostics and Nowdiagnostics.

When was Specific Diagnostics founded?

Specific Diagnostics was founded in 2011.

Where is Specific Diagnostics' headquarters located?

Specific Diagnostics' headquarters is located in Mountain View, CA, US.

How much has Specific Diagnostics raised to-date?

As of Apr 29, 2021, Specific Diagnostics has raised a total of $15.9M (USD).

How many employees does Specific Diagnostics have?

Specific Diagnostics has 175 employees as of Feb 5, 2024.

Specific Diagnostics - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • Diagnostics
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Antibiotic Susceptibility
Tags
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified